Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Description of the Head of Australia, Canada, Singapore, Switzerland Agencies Consortium - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 211692
Later capture
Archived Description of the Head of Australia, Canada, Singapore, Switzerland Agencies Consortium - Canada.ca
Jan 2, 2026
hc-20260101
ID 428931
updated1 sections changed; 1 added; 1 removed
1 sections changed1 added1 removed+2 / -3 linesChange ratio: 12%
--- +++ @@ -1,4 +1,4 @@-Description of the Head of Australia, Canada, Singapore, Switzerland Agencies Consortium+Archived Description of the Head of Australia, Canada, Singapore, Switzerland Agencies Consortium Globalisation of health products including rapid emergence of new technologies, increased international flow of health products and limited resources affects the capacity of a single regulatory agency to address health risks and promote timely access to safe therapeutic products. Recognising these challenges and the importance of international collaboration among like-minded health regulatory agencies, the Head of Agencies Consortium was established in 2007 as a means to promote regulatory convergence and foster synergy to address scientific and regulatory issues ( Terms of Reference ).@@ -17,5 +17,4 @@ Assessment reports for pharmaceuticals including generic drugs and new chemical entities, and Coordination of involvement of technical experts in the International Conference on Harmonisation (ICH) working groups, and the collaboration on the Information Technology (IT)-architecture. Page details-Date modified:-2017-09-06+2017-09-08